202 related articles for article (PubMed ID: 12011971)
1. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis.
Kaartinen V; Haataja L; Nagy A; Heisterkamp N; Groffen J
Int J Mol Med; 2002 Jun; 9(6):563-70. PubMed ID: 12011971
[TBL] [Abstract][Full Text] [Related]
2. RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation.
Patel S; Takagi KI; Suzuki J; Imaizumi A; Kimura T; Mason RM; Kamimura T; Zhang Z
J Am Soc Nephrol; 2005 Jul; 16(7):1977-84. PubMed ID: 15901767
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
4. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
Lee HT; Kay EP
Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
[TBL] [Abstract][Full Text] [Related]
6. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA.
Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E
Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608
[TBL] [Abstract][Full Text] [Related]
7. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
[TBL] [Abstract][Full Text] [Related]
8. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
9. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
10. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
11. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
Smith PC; Cáceres M; Martinez J
J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).
Graness A; Giehl K; Goppelt-Struebe M
Cell Signal; 2006 Apr; 18(4):433-40. PubMed ID: 15970428
[TBL] [Abstract][Full Text] [Related]
13. The COOH-terminal end of R-Ras alters the motility and morphology of breast epithelial cells through Rho/Rho-kinase.
Jeong HW; Nam JO; Kim IS
Cancer Res; 2005 Jan; 65(2):507-15. PubMed ID: 15695393
[TBL] [Abstract][Full Text] [Related]
14. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells.
Cho HJ; Yoo J
Cell Biol Int; 2007 Oct; 31(10):1225-30. PubMed ID: 17537651
[TBL] [Abstract][Full Text] [Related]
15. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain.
Sarasa-Renedo A; Tunç-Civelek V; Chiquet M
Exp Cell Res; 2006 May; 312(8):1361-70. PubMed ID: 16448650
[TBL] [Abstract][Full Text] [Related]
16. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
17. RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells.
Laplante I; Béliveau R; Paquin J
J Neurobiol; 2004 Sep; 60(3):289-307. PubMed ID: 15281068
[TBL] [Abstract][Full Text] [Related]
18. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.
Wicki A; Lehembre F; Wick N; Hantusch B; Kerjaschki D; Christofori G
Cancer Cell; 2006 Apr; 9(4):261-72. PubMed ID: 16616332
[TBL] [Abstract][Full Text] [Related]
19. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
20. RhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specific.
Bailly K; Ridley AJ; Hall SM; Haworth SG
Circ Res; 2004 May; 94(10):1383-91. PubMed ID: 15087418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
